4-((4-Chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)morpholine

Catalog No. :
ACCXOK011
CAS No. :
2382664-58-4
Molecular Formula :
C21H22ClN3O5S
Molecular Weight :
463.94

IUPAC Name:4-((4-chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)morpholine

4-((4-Chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((4-Chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)morpholine
IUPAC Name4-((4-chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)morpholine
MDL No.MFCD32691148
Molecular FormulaC21H22ClN3O5S
Molecular Weight463.94
SMILESO=S(N1C(CN2CCOCC2)=CC3=C(Cl)C(C4OCCO4)=CN=C31)(C5=CC=CC=C5)=O
InChI KeyHEZAKWRPGZTVOD-UHFFFAOYSA-N
Synonym1H-Pyrrolo[2,3-b]pyridine, 4-chloro-5-(1,3-dioxolan-2-yl)-2-(4-morpholinylmethyl)-1-(phenylsulfonyl)-;4-((4-chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)morpholine
CAS No.2382664-58-4

Synthetic Route by SureRoute

1. ACCXOK011 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXOK011 route product structure diagram
    ACCXOK0112382664-58-4
Inquiry

2. ACCXOK011 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACCXOK011 route product structure diagram
    ACCXOK0112382664-58-4
Inquiry

Comments (0)